en

PRODUCT DETAIL

IMJUDO 20 mg/ml koncentrát na infúzny roztok

Code 3202E
MA number EU/1/22/1713/002
Product Form: con inf 1x15 ml/300 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01FX Other monoclonal antibodies and antibody drug conjugates
L01FX20 Tremelimumab
Shelf life: 48
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 20.02.2023
Validity: 20.02.2028
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 03.03.2023
eu-flag.png sk-flag.png